This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignee: Purdue Research Foundation. Active years: 2005-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Silver Springs, MD (US) (2005 - 2007)
- Silver Spring, MD (US) (2010)
- Edina, MN (US) (2013)
Company Filing History:
Years Active: 2005-2013
Title: Nicole D Zantek: Innovator in Cancer Therapeutics
Introduction
Nicole D Zantek is a prominent inventor based in Silver Springs, MD (US). She has made significant contributions to the field of cancer research, particularly in the development of therapeutic targets for metastatic disease. With a total of 4 patents to her name, Zantek's work is paving the way for innovative treatments in oncology.
Latest Patents
Among her latest patents, Zantek has focused on EphA2 as a therapeutic target for cancer. The present invention is directed to compounds and methods for the treatment of metastatic disease. The compounds of this invention have specificity for EphA2, an epithelial cell tyrosine kinase that is overexpressed in metastatic tumor cells. These compounds may be provided in a pharmaceutical composition for the treatment of metastatic cancer, showcasing her commitment to advancing cancer therapies.
Career Highlights
Zantek is affiliated with the Purdue Research Foundation, where she continues to explore innovative solutions in cancer treatment. Her research is characterized by a strong focus on the molecular mechanisms underlying cancer progression, particularly through the lens of EphA2.
Collaborations
Throughout her career, Zantek has collaborated with notable colleagues, including Michael Scott Kinch and Patrick W Hein. These partnerships have enriched her research and expanded the impact of her inventions in the scientific community.
Conclusion
Nicole D Zantek is a trailblazer in the field of cancer therapeutics, with a strong portfolio of patents that reflect her innovative spirit and dedication to improving patient outcomes. Her work continues to inspire advancements in cancer treatment and research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile